Annual Operating Profit:
$75.56M+$62.15M(+463.72%)Summary
- As of today, SUPN annual operating income is $75.56 million, with the most recent change of +$62.15 million (+463.72%) on December 31, 2024.
- During the last 3 years, SUPN annual operating profit has fallen by -$3.94 million (-4.96%).
- SUPN annual operating profit is now -56.97% below its all-time high of $175.60 million, reached on December 31, 2020.
Performance
SUPN Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Operating Profit:
$11.14M+$13.74M(+529.16%)Summary
- As of today, SUPN quarterly operating income is $11.14 million, with the most recent change of +$13.74 million (+529.16%) on June 30, 2025.
- Over the past year, SUPN quarterly operating profit has dropped by -$7.07 million (-38.83%).
- SUPN quarterly operating profit is now -80.15% below its all-time high of $56.14 million, reached on September 30, 2020.
Performance
SUPN Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Operating Profit:
$67.94M-$7.07M(-9.43%)Summary
- As of today, SUPN TTM operating income is $67.94 million, with the most recent change of -$7.07 million (-9.43%) on June 30, 2025.
- Over the past year, SUPN TTM operating profit has increased by +$27.30 million (+67.18%).
- SUPN TTM operating profit is now -62.90% below its all-time high of $183.12 million, reached on March 31, 2021.
Performance
SUPN TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
SUPN Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +463.7% | -38.8% | +67.2% |
| 3Y3 Years | -5.0% | -7.8% | +0.3% |
| 5Y5 Years | -49.1% | -79.0% | -62.0% |
SUPN Operating Profit Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -5.0% | +463.7% | -72.0% | +166.3% | -9.4% | +1107.5% |
| 5Y | 5-Year | -57.0% | +463.7% | -80.2% | +166.3% | -62.9% | +1107.5% |
| All-Time | All-Time | -57.0% | +222.0% | -80.2% | +157.5% | -62.9% | +207.3% |
SUPN Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $11.14M(+529.2%) | $67.94M(-9.4%) |
| Mar 2025 | - | -$2.60M(-113.3%) | $75.01M(+2.3%) |
| Dec 2024 | $75.56M(+463.7%) | $19.56M(-50.9%) | $73.36M(+0.8%) |
| Sep 2024 | - | $39.83M(+118.7%) | $72.78M(+79.1%) |
| Jun 2024 | - | $18.21M(+528.8%) | $40.64M(+622.3%) |
| Mar 2024 | - | -$4.25M(-122.4%) | $5.63M(-58.0%) |
| Dec 2023 | $13.40M(-70.6%) | $18.99M(+147.2%) | $13.40M(-49.1%) |
| Sep 2023 | - | $7.68M(+145.7%) | $26.34M(+49.5%) |
| Jun 2023 | - | -$16.80M(-576.0%) | $17.63M(-62.1%) |
| Mar 2023 | - | $3.53M(-88.9%) | $46.51M(+2.0%) |
| Dec 2022 | $45.61M(-42.6%) | $31.93M(+3179.1%) | $45.61M(+46.2%) |
| Sep 2022 | - | -$1.04M(-108.6%) | $31.20M(-53.9%) |
| Jun 2022 | - | $12.09M(+359.3%) | $67.72M(-9.2%) |
| Mar 2022 | - | $2.63M(-85.0%) | $74.60M(-26.3%) |
| Dec 2021 | $79.50M(-54.7%) | $17.52M(-50.6%) | $101.20M(-21.2%) |
| Sep 2021 | - | $35.48M(+87.1%) | $128.48M(-13.9%) |
| Jun 2021 | - | $18.96M(-35.1%) | $149.13M(-18.6%) |
| Mar 2021 | - | $29.23M(-34.7%) | $183.12M(+0.1%) |
| Dec 2020 | $175.60M(+18.2%) | $44.80M(-20.2%) | $182.90M(+2.2%) |
| Sep 2020 | - | $56.14M(+6.0%) | $178.92M(+10.1%) |
| Jun 2020 | - | $52.95M(+82.5%) | $162.50M(+6.8%) |
| Mar 2020 | - | $29.01M(-28.9%) | $152.16M(+2.4%) |
| Dec 2019 | $148.57M(+2.9%) | $40.82M(+2.7%) | $148.57M(+0.7%) |
| Sep 2019 | - | $39.73M(-6.7%) | $147.61M(+1.6%) |
| Jun 2019 | - | $42.60M(+67.5%) | $145.36M(+5.0%) |
| Mar 2019 | - | $25.43M(-36.2%) | $138.48M(-4.1%) |
| Dec 2018 | $144.44M(+45.1%) | $39.85M(+6.4%) | $144.44M(+4.0%) |
| Sep 2018 | - | $37.48M(+4.9%) | $138.93M(+12.2%) |
| Jun 2018 | - | $35.72M(+13.8%) | $123.80M(+8.5%) |
| Mar 2018 | - | $31.39M(-8.6%) | $114.15M(+14.7%) |
| Dec 2017 | $99.54M | $34.34M(+53.7%) | $99.54M(+22.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | $22.34M(-14.3%) | $81.49M(+3.2%) |
| Jun 2017 | - | $26.07M(+55.3%) | $78.99M(+22.3%) |
| Mar 2017 | - | $16.79M(+3.0%) | $64.57M(+19.1%) |
| Dec 2016 | $54.22M(+160.1%) | $16.30M(-17.9%) | $54.22M(+18.4%) |
| Sep 2016 | - | $19.84M(+70.4%) | $45.80M(+51.3%) |
| Jun 2016 | - | $11.64M(+80.9%) | $30.27M(+34.7%) |
| Mar 2016 | - | $6.44M(-18.3%) | $22.47M(+12.0%) |
| Dec 2015 | $20.84M(+494.9%) | $7.88M(+82.9%) | $20.07M(+18.6%) |
| Sep 2015 | - | $4.31M(+12.1%) | $16.92M(-59.5%) |
| Jun 2015 | - | $3.84M(-4.7%) | $41.77M(+0.2%) |
| Mar 2015 | - | $4.03M(-14.7%) | $41.69M(+72.0%) |
| Dec 2014 | -$5.28M(+91.5%) | $4.73M(-83.8%) | $24.23M(+197.5%) |
| Sep 2014 | - | $29.17M(+676.5%) | $8.14M(+121.3%) |
| Jun 2014 | - | $3.76M(+128.0%) | -$38.20M(+33.5%) |
| Mar 2014 | - | -$13.42M(-18.2%) | -$57.43M(+7.2%) |
| Dec 2013 | -$61.92M(-46.8%) | -$11.36M(+33.9%) | -$61.92M(+2.2%) |
| Sep 2013 | - | -$17.18M(-11.0%) | -$63.30M(-8.4%) |
| Jun 2013 | - | -$15.48M(+13.6%) | -$58.42M(-11.9%) |
| Mar 2013 | - | -$17.91M(-40.5%) | -$52.20M(-23.8%) |
| Dec 2012 | -$42.17M(-11.7%) | -$12.74M(-3.7%) | -$42.17M(-6.3%) |
| Sep 2012 | - | -$12.29M(-32.8%) | -$39.67M(-6.4%) |
| Jun 2012 | - | -$9.26M(-17.5%) | -$37.29M(-2.4%) |
| Mar 2012 | - | -$7.88M(+23.1%) | -$36.43M(+3.5%) |
| Dec 2011 | -$37.75M(+5.9%) | -$10.24M(-3.3%) | -$37.75M(+19.5%) |
| Sep 2011 | - | -$9.91M(-18.1%) | -$46.90M(-26.8%) |
| Jun 2011 | - | -$8.40M(+8.7%) | -$36.98M(-29.4%) |
| Mar 2011 | - | -$9.20M(+52.6%) | -$28.59M(-47.4%) |
| Dec 2010 | -$40.12M(-1099.1%) | -$19.39M(-41.1%) | -$19.39M(-41.1%) |
| Dec 2009 | $4.02M(+115.5%) | -$13.74M | -$13.74M |
| Dec 2008 | -$25.86M(-35.8%) | - | - |
| Dec 2007 | -$19.05M | - | - |
FAQ
- What is Supernus Pharmaceuticals, Inc. annual operating income?
- What is the all-time high annual operating profit for Supernus Pharmaceuticals, Inc.?
- What is Supernus Pharmaceuticals, Inc. annual operating profit year-on-year change?
- What is Supernus Pharmaceuticals, Inc. quarterly operating income?
- What is the all-time high quarterly operating profit for Supernus Pharmaceuticals, Inc.?
- What is Supernus Pharmaceuticals, Inc. quarterly operating profit year-on-year change?
- What is Supernus Pharmaceuticals, Inc. TTM operating income?
- What is the all-time high TTM operating profit for Supernus Pharmaceuticals, Inc.?
- What is Supernus Pharmaceuticals, Inc. TTM operating profit year-on-year change?
What is Supernus Pharmaceuticals, Inc. annual operating income?
The current annual operating profit of SUPN is $75.56M
What is the all-time high annual operating profit for Supernus Pharmaceuticals, Inc.?
Supernus Pharmaceuticals, Inc. all-time high annual operating income is $175.60M
What is Supernus Pharmaceuticals, Inc. annual operating profit year-on-year change?
Over the past year, SUPN annual operating income has changed by +$62.15M (+463.72%)
What is Supernus Pharmaceuticals, Inc. quarterly operating income?
The current quarterly operating profit of SUPN is $11.14M
What is the all-time high quarterly operating profit for Supernus Pharmaceuticals, Inc.?
Supernus Pharmaceuticals, Inc. all-time high quarterly operating income is $56.14M
What is Supernus Pharmaceuticals, Inc. quarterly operating profit year-on-year change?
Over the past year, SUPN quarterly operating income has changed by -$7.07M (-38.83%)
What is Supernus Pharmaceuticals, Inc. TTM operating income?
The current TTM operating profit of SUPN is $67.94M
What is the all-time high TTM operating profit for Supernus Pharmaceuticals, Inc.?
Supernus Pharmaceuticals, Inc. all-time high TTM operating income is $183.12M
What is Supernus Pharmaceuticals, Inc. TTM operating profit year-on-year change?
Over the past year, SUPN TTM operating income has changed by +$27.30M (+67.18%)